Neuraxis, INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCarmel, IN
US patents16
SAM.gov UEIHDD6GGEB4HT9
CAGE code73QP0
Incorporated inDE
Brands
NeurAxis
NeurAxis NeurostimulationThis company sells these brands.
- neuromodulation therapies
- debilitating conditions
- Adults
- Pediatrics
- RED™
- irritable bowel syndrome
- functional dyspepsia
- FD-related nausea symptoms
- patients suffering
Named on the company’s own website, read JUL 29, 2026
What they make
Monitor, Esophageal Motility, Anorectal Motility, And TubeNon-Implanted Nerve Stimulator For Pain Associated With Irritable Bowel Syndrome (Ibs)Stimulator, Electro-AcupunctureSystem, Gastrointestinal Motility (Electrical)
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
16 US patents granted 2013–2025, 9 of them in the five years to SEP 2025.
Medical technology 14Pharmaceuticals 2
- Auricular peripheral nerve field stimulator and method of operating sameUS 12,383,461 · granted AUG 12, 2025
- Device and method for eradicating pathogens in nasal passagesUS 12,324,926 · granted JUN 10, 2025
- Methods of treating disease using auricular peripheral nerve field stimulationUS 12,285,602 · granted APR 29, 2025
- Auricular nerve field stimulation deviceUS 12,097,371 · granted SEP 24, 2024
- Auricular peripheral nerve field stimulator and method of operating sameUS 12,029,701 · granted JUL 9, 2024
Newest 5 shown · Granted to Neuraxis, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Neuraxis, INC | Carmel | IN | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.